Cetirizine PCD Pharma Franchise Company

Cafoli Lifecare offers a Cetirizine range of 27 formulations across tablets, syrup and suspension, manufactured in WHO-GMP certified facilities. Distributors seeking a dependable antihistamine line can secure district-wise monopoly franchise rights on this high-volume molecule.

What is Cetirizine?

Cetirizine is a second-generation antihistamine that selectively blocks peripheral H1 receptors, relieving sneezing, runny nose, watery eyes and itching with minimal sedation compared to first-generation agents. It is widely used for allergic rhinitis and chronic urticaria. Detailed drug information is available on MedlinePlus.

Therapeutic Applications

Cetirizine is indicated for seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, allergic conjunctivitis and pruritic skin conditions. It is prescribed by general physicians, ENT specialists, dermatologists, paediatricians and pulmonologists, and syrup and suspension strengths make the range suitable for paediatric practice as well.

Why Cetirizine is a High-Potential Molecule for Distributors

Cetirizine is one of the highest-moving antihistamines in Indian retail pharmacy, driven by rising allergic rhinitis prevalence, urban air pollution and strong brand recall at the chemist counter. Repeat purchases, paediatric syrup demand and combination potential with decongestants keep prescriptions steady through the year, while seasonal allergy peaks deliver predictable volume spikes for franchise partners.

Why Choose Cafoli Lifecare

Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.

References

1. MedlinePlus: Cetirizine
2. PubChem: Cetirizine
3. PubMed: Cetirizine in allergic rhinitis